Back to top

earnings-preview: Archive

Zacks Equity Research

Johnson Controls (JCI) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Evaluate the expected performance of Johnson Controls (JCI) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

JCIPositive Net Change

Zacks Equity Research

Stay Ahead of the Game With Fortinet (FTNT) Q3 Earnings: Wall Street's Insights on Key Metrics

Besides Wall Street's top-and-bottom-line estimates for Fortinet (FTNT), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.

FTNTPositive Net Change

Zacks Equity Research

Insights Into Robinhood Markets (HOOD) Q3: Wall Street Projections for Key Metrics

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Robinhood Markets (HOOD), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.

HOODPositive Net Change

Zacks Equity Research

Countdown to McDonald's (MCD) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for McDonald's (MCD), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.

MCDNegative Net Change

Zacks Equity Research

Gear Up for Iron Mountain (IRM) Q3 Earnings: Wall Street Estimates for Key Metrics

Besides Wall Street's top-and-bottom-line estimates for Iron Mountain (IRM), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.

IRMPositive Net Change

Zacks Equity Research

Countdown to Humana (HUM) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Humana (HUM), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.

HUMNegative Net Change

Zacks Equity Research

Insights Into Duolingo (DUOL) Q3: Wall Street Projections for Key Metrics

Beyond analysts' top-and-bottom-line estimates for Duolingo (DUOL), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.

DUOLPositive Net Change

Zacks Equity Research

Stay Ahead of the Game With Yum (YUM) Q3 Earnings: Wall Street's Insights on Key Metrics

Evaluate the expected performance of Yum (YUM) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

YUMNegative Net Change

Zacks Equity Research

Exploring Analyst Estimates for Fair Isaac (FICO) Q4 Earnings, Beyond Revenue and EPS

Beyond analysts' top-and-bottom-line estimates for Fair Isaac (FICO), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.

FICOPositive Net Change

Zacks Equity Research

Ahead of McKesson (MCK) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Beyond analysts' top-and-bottom-line estimates for McKesson (MCK), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.

MCKNegative Net Change

Zacks Equity Research

FS KKR Capital (FSK) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates

Beyond analysts' top-and-bottom-line estimates for FS KKR Capital (FSK), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.

FSKPositive Net Change

Zacks Equity Research

Countdown to Cencora (COR) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS

Evaluate the expected performance of Cencora (COR) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

CORNegative Net Change

Zacks Equity Research

ADM (ADM) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Beyond analysts' top-and-bottom-line estimates for ADM (ADM), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.

ADMNegative Net Change

Zacks Equity Research

Curious about Emerson Electric (EMR) Q4 Performance? Explore Wall Street Estimates for Key Metrics

Beyond analysts' top-and-bottom-line estimates for Emerson Electric (EMR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.

EMRPositive Net Change

Zacks Equity Research

Unlocking Q4 Potential of Qualcomm (QCOM): Exploring Wall Street Estimates for Key Metrics

Beyond analysts' top-and-bottom-line estimates for Qualcomm (QCOM), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.

QCOMPositive Net Change

Zacks Equity Research

Insights Into MetLife (MET) Q3: Wall Street Projections for Key Metrics

Besides Wall Street's top-and-bottom-line estimates for MetLife (MET), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.

METPositive Net Change

Urmimala Biswas

QBTS vs. QUBT Ahead of Q3 Earnings: Which Quantum Stock Leads?

D-Wave's record cash, rising revenues and Advantage2 rollout give it the edge over QUBT ahead of Q3 earnings.

QUBTPositive Net Change QBTSPositive Net Change

Zacks Equity Research

Zymeworks Inc. (ZYME) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Zymeworks (ZYME) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ZYMENegative Net Change ADPTPositive Net Change

Zacks Equity Research

Viatris (VTRS) Expected to Beat Earnings Estimates: Should You Buy?

Viatris (VTRS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

VTRSNo Net Change CORNegative Net Change

Zacks Equity Research

Wynn Resorts (WYNN) Reports Next Week: Wall Street Expects Earnings Growth

Wynn (WYNN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

WYNNNegative Net Change

Zacks Equity Research

Earnings Preview: Dentsply International (XRAY) Q3 Earnings Expected to Decline

Dentsply (XRAY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

XRAYPositive Net Change MCKNegative Net Change

Zacks Equity Research

Unusual Machines, Inc. (UMAC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Unusual Machines, Inc. (UMAC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

UMACNegative Net Change APPPositive Net Change

Zacks Equity Research

UWM Holdings Corporation (UWMC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

UWM (UWMC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

UWMCPositive Net Change AGMPositive Net Change

Zacks Equity Research

Victory Capital Holdings (VCTR) Reports Next Week: Wall Street Expects Earnings Growth

Victory Capital (VCTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

VCTRPositive Net Change GCMGNegative Net Change

Zacks Equity Research

Tandem Diabetes Care, Inc. (TNDM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Tandem Diabetes Care (TNDM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TNDMNegative Net Change